Wistar researchers discover possible new trea : comparemela.

Zachary Schug, Ph.D., assistant professor at The Wistar Institute, has published a new paper in the journal Nature Cancer demonstrates a double-acting mechanism for fighting a particularly aggressive, difficult-to-treat form of breast cancer. Schug’s research shows how silencing a certain gene, ACSS2, may improve existing treatments for patients.

Related Keywords

Pennsylvania , United States , University Of Pennsylvania , Philadelphia , Toshitha Kannan , Josephm Salvino , Wistar Proteomic , Gauri Mirji , Seamus Oconnor , Katelynd Miller , Kathryne Wellen , Zachary Schug , Steven Zhao , Susang Komen , Reyes Acosta , Yellamellivv Srikanth , Rahuls Shinde , Andrew Kossenkov , Fabrizio Bertolazzi , Danielt Claiborne , Zacharyt Schug , Katherinea Pniewski , Sara Papp , Michael Hulse , University Of Bologna , Method Of Research , Ronald Caplan Cancer Center , Wistar Institute , Ww Smith Charitable , National Institutes Of Health , American Cancer Society Rena , Cellular Oncogenesis Program Of The Ellen , V Foundation For Cancer Research , Pennsylvania Breast Cancer Coalition , National Cancer Institute , Cellular Oncogenesis Program , Seamuso Connor , National Institutes , Charitable Trust , Pennsylvania Breast Cancer , Victor Damone Postdoctoral Fellowship , Wistar Molecular Screening Facility , Genomics Facility , Metabolomic Facility ,